Trials / Completed
CompletedNCT04871971
Glycaemic Response and Insulinaemic Response for Nutralys S85 Plus and Whey Protein
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Oxford Brookes University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
A comparison of the glycaemic response and insulinaemic response to glucose, Nutralys S85 Plus pea protein and whey protein using a single-blind, randomised, repeat measure, crossover design trial.
Detailed description
A single-blind, randomised, repeat measure, crossover design trial will be used to study the glycaemic response and insulinaemic response following consumption of five products: one reference product (50 g available carbohydrate Glucose) and four test products (50 g available carbohydrate Glucose with 10 g NUTRALYS®S85 Plus pea protein, 50 g available carbohydrate Glucose with 20 g NUTRALYS®S85 Plus pea protein, 50 g available carbohydrate Glucose with 10 g Whey protein concentrate and 50 g available carbohydrate Glucose with 20 g Whey protein concentrate).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 10 g NUTRALYS®S85 Plus pea protein | To determine the glycaemic response and insulinaemic response to 50g Glucose + 10 g NUTRALYS®S85 Plus pea protein. |
| DIETARY_SUPPLEMENT | 20 g NUTRALYS®S85 Plus pea protein | To determine the glycaemic response and insulinaemic response to 50g Glucose + 20 g NUTRALYS®S85 Plus pea protein. |
| DIETARY_SUPPLEMENT | 10 g Whey protein concentrate | To determine the glycaemic response and insulinaemic response to 50g Glucose + 10 g Whey protein concentrate. |
| DIETARY_SUPPLEMENT | 20 g Whey protein concentrate | To determine the glycaemic response and insulinaemic response to 50g Glucose + 20 g Whey protein concentrate. |
| DIETARY_SUPPLEMENT | 50 g Glucose | To determine the glycaemic response and insulinaemic response to 50g Glucose |
Timeline
- Start date
- 2021-09-15
- Primary completion
- 2022-07-13
- Completion
- 2022-08-29
- First posted
- 2021-05-04
- Last updated
- 2022-09-07
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04871971. Inclusion in this directory is not an endorsement.